NEONATAL HAEMOCHROMATOSIS

This adverse event was reported 4 times

These drugs are most commonly taken by patients reporting NEONATAL HAEMOCHROMATOSIS:

# Drug Count
0 CARGLUMIC ACID 1
1 GLATIRAMER ACETATE 1
2 HUMAN IMMUNOGLOBULIN G 1
3 SODIUM PHENYLBUTYRATE 1
See all common drugs associated with NEONATAL HAEMOCHROMATOSIS

NEONATAL HAEMOCHROMATOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM PHENYLBUTYRATE 1 0.0024
1 CARGLUMIC ACID 1 0.0013
2 HUMAN IMMUNOGLOBULIN G 1 0.0000
3 GLATIRAMER ACETATE 1 0.0000
See all drugs enriched for association with NEONATAL HAEMOCHROMATOSIS

These drug classes are most commonly taken by patients reporting NEONATAL HAEMOCHROMATOSIS:

# Drug class Count
0 Carbamoyl Phosphate Synthetase 1 Activator [EPC] 1
1 Human Immunoglobulin G [EPC] 1
See all common drug classes associated with NEONATAL HAEMOCHROMATOSIS

NEONATAL HAEMOCHROMATOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Carbamoyl Phosphate Synthetase 1 Activator [EPC] 1 0.0013
1 Human Immunoglobulin G [EPC] 1 0.0000
See all drug classes enriched for association with NEONATAL HAEMOCHROMATOSIS